(Q51873139)

15 April 2018

title

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. (English)

1 reference

15 April 2018

0 references

1 reference

1

1 reference

15 April 2018

Gary R. Cutter

3

object named as

G Cutter

0 references

author name string

R Horwitz

2

1 reference

15 April 2018

T Tyry

4

1 reference

15 April 2018

D Campagnolo

5

1 reference

15 April 2018

T Vollmer

6

1 reference

15 April 2018

publication date

19 January 2009

1 reference

15 April 2018

Multiple Sclerosis Journal

published in

1 reference

15 April 2018

volume

15

1 reference

15 April 2018

issue

3

1 reference

15 April 2018

page(s)

385-392

1 reference

15 April 2018

Anxiety disorders and their clinical correlates in multiple sclerosis patients.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Treatment of depression for patients with multiple sclerosis in neurology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Validation of the NARCOMS registry: diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Cancer and comorbidity in older patients: a descriptive profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Depressive symptoms and mortality in a prospective study of 2,558 older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Predictive Value of the CES-D in Detecting Depression Among Candidates for Disease-Modifying Multiple Sclerosis Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

The Goldman Consensus statement on depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Psychiatric manifestations of multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Psychotic disorders in MS: Population-based evidence of an association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Prevalence and correlates of depression among veterans with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Lifetime prevalence of psychotic and bipolar I disorders in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Prevalence and incidence studies of anxiety disorders: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

Comorbidity, socioeconomic status and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099477

21 January 2018

Identifiers

DOI

10.1177/1352458508099477

1 reference

15 April 2018

PubMed ID

19153176

1 reference

15 April 2018